Human Primary Diabetic Lung Endothelial Cells
Quick Actions
Product Overview
Description
Human Primary Diabetic Lung Endothelial Cells (DLEC) are isolated from lung tissue (mixed pulmonary vascular bed) associated with Type 2 Diabetes Mellitus. These cells exhibit pulmonary endothelial characteristics with diabetic dysfunction, suitable for studying diabetic lung disease, pulmonary vascular complications, and endothelial dysfunction.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPD013
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Positive for endothelial markers: Positive for endothelial cell
markers: CD31 (PECAM-1) and VE-Cadherin by
immunofluorescence staining or FACS .
- Cells are pre-coated with PECAM-1 antibody during isolation using magnetic beads.
Quick Facts
Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
